Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the PPARγ ligand troglitazone

Autor: K von Schwarzenberg, Katharina M. Brauer, Peter Brossart, Anita Bringmann, A. Schaub, Stefanie Ae Held
Rok vydání: 2009
Předmět:
Zdroj: Cellular and Molecular Life Sciences. 66:1295-1308
ISSN: 1420-9071
1420-682X
DOI: 10.1007/s00018-009-8542-7
Popis: In order to analyze the effects of peroxisome proliferator-activated receptor-gamma (PPARgamma) activation on renal cell carcinomas we utilized several cell lines that were treated with the high affinity PPARgamma agonist, troglitazone. Incubation of RCC cells with troglitazone resulted in reduced secretion of growth factors that was due to the inhibition of MAP kinase signaling and reduced nuclear localized expression of relB and HIF1alpha. Interestingly, the cell lines used showed a different sensitivity towards apoptosis induction that did not correlate with the inhibition of growth factors or expression of pro- and antiapoptotic molecules. To overcome this resistance the cells were treated with a combination of troglitazone and the proteasome inhibitor, bortezomib. The combination of both compounds induced apoptosis even in cells resistant to both agents alone, due to increased induction of ER-stress and caspase-3 mediated cell death.
Databáze: OpenAIRE